Sexually transmitted infections

California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.

The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.

Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.

The CDC released the first set of new STI guidelines since 2015. What are the notable updates that primary care physicians should know? Find out here.

Rates of reported STD cases in the US have reached an all-time high, again. Are you caught up on the latest CDC numbers? Try your hand at these 7 questions to find out.

SAMPLE: Approximately what percentage of the total US population had an STI at a given point in 2018? Plus 6 more questions on STI trends based on the latest CDC data.

Over 80% of college students surveyed said they were "likely" or "extremely likely" to use STI self-testing services if they could take it in the privacy of their own home.

Sexually distancing and declines in STD testing due to COVID-19 may have caused the recent decline in reported cases of syphilis, gonorrhea, and chlamydia in the US.

How much do you know about syphilis prevention, screening, and treatment? Test yourself with these 5 true or false questions.

How many young adults in the US actually receive their recommended doses of HPV vaccine? Take this 7-question quiz on a new report to learn more about the trends.

More young adults in the US are getting vaccinated against human papillomavirus, rising almost 50% in 5 years, according to a new report.

The underpinnings of the global HIV and STI epidemics are inextricable. A new report looks at combined solutions. We offer highlights.

Sexually transmitted infection cases have reached an all-time high at an alarming speed. Test your knowledge of different treatment options with our new case challenge. 

Take this brief test on the updated CDC guidelines to give yourself a refresher course in STD management and stay current with the latest practices.

If we had a vaccine that was as effective at reducing HIV infection as circumcision, it would be a recommended vaccine here in the US, argues this pediatrician.

Digital abnormalities; oral candidiasis and HIV-infection; extra dose of MMR; penile rash . . . here: a range of topics to challenge you.

Here: 5 things (at least) you may not know about human viral hepatitis.

Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.

English- and Spanish-speaking parents cited widely differing reasons for avoiding vaccination for their eligible daughters or failing to ensure the 3 doses were received.

Most parents of boys aged 9 to 18 years do not know that an HPV vaccine is available for their sons. One major factor is a lack of information. This is where you play a vital role.

The FDA today advised physicians prescribing rituximab to screen and monitor all patients taking the drug for evidence of hepatitis B infection.

A 15-year prospective study shows that although cryoglobulinemic syndrome has no influence on overall survival of hepatitis C patients, it does influence the risk for other comorbidities.

Not only does the welcome long-term survival of HIV-infected patients put them at risk of ordinary age-related bone loss, antiretroviral therapy leads to a decline in bone mineral density. What can be done?

Because of this patient’s recent travel history to Africa, the penile lesions were cultured, and Haemophilus ducreyi was isolated, confirming the clinical suspicion of chancroid.

Approval of a blood test that identifies the genotype of hepatitis C virus that has infected a patient can be expected to improve the effectiveness of treatment for chronic hepatitis C with new antivirals.